VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $183,000 | -57.2% | 12,669 | -50.6% | 0.01% | -58.3% |
| Q2 2017 | $428,000 | +205.7% | 25,633 | +74.9% | 0.01% | +200.0% |
| Q1 2017 | $140,000 | -22.2% | 14,655 | +24.6% | 0.00% | -33.3% |
| Q4 2016 | $180,000 | -20.7% | 11,765 | +23.2% | 0.01% | -33.3% |
| Q3 2016 | $227,000 | -3.0% | 9,552 | -6.2% | 0.01% | 0.0% |
| Q2 2016 | $234,000 | +15.3% | 10,188 | +410.9% | 0.01% | -10.0% |
| Q4 2015 | $203,000 | -46.3% | 1,994 | -5.9% | 0.01% | -52.4% |
| Q3 2015 | $378,000 | +58.2% | 2,118 | +27.0% | 0.02% | +40.0% |
| Q4 2014 | $239,000 | 0.0% | 1,668 | -8.6% | 0.02% | -11.8% |
| Q3 2014 | $239,000 | -48.9% | 1,824 | -48.6% | 0.02% | -65.3% |
| Q1 2014 | $468,000 | – | 3,549 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |